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ABSTRACT 
Potassium transport channels regulate cellular excitability and membrane potentials. Dys-
function of potassium channels may happen under certain pathophysiological conditions via 
post-translational modification (PTM), inducing the S-glutathionylation, in oxidative stress. 
Here, we try to demonstrate the effect of ROS on Kir4.1 and Kir5.1 channel. It is found that the 
target subunit of ROS is Kir5.1 instead of Kir4.1 subunit. Kir4.1-Kir5.1 heteromeric channel is 
inhibited by different kinds of oxidants. The patch clamp study confirmed that these oxidants 
work on the intracellular side of the Kir5.1 subunit. Further experiments demonstrate that the in-
hibition of Kir4.1-Kir5.1 channels is through S-glutathionylation of the Kir5.1 subunit on 
Cys158. The information we find may help to better understand the Kir4.1 and Kir5.1 channel 
modulation mechanism in various pathophysiological conditions, such as oxidative stress. 
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1     INTRODUCTION  
Inwardly rectifying potassium (Kir) channels are distinct from the conventional voltage-
gated potassium (Kv) channels. There are classical Kir channels, G protein-gated Kir channels, 
K
+
 transport channels and ATP-sensitive K
+
 channels in this family. The third group of Kir 
channels, such as Kir1.1, and Kir4.1, play a role as K
+
 transporters (Butt-Kalsi, 2006). The 
Kir4.1 is composed of homomeric channels or heteromeric channels with Kir5.1 in tetrameric 
forms. The heteromeric Kir4.1-Kir5.1 channel endues extended functional range of Kir channel 
[1-3]. Kir4.1-Kir5.1 channel is regulated by different G protein coupled receptors of neurotrans-
mitters [4], as well as post-translational modification (PTM), such as phosphorylation via PKC 
[5]. Therefore, like other ion channels [6-9], Kir4.1 and Kir4.1-Kir5.1 channel are possibly regu-
lated by PTMs (e.g. S-nitrosylation, S-glutathionylation and etc.) in pathological conditions, es-
pecially oxidative stress. 
Oxidative stress occurs when the production of reactive oxygen species (ROS) overwhelms 
the anti-oxidant defense system of the cell. Production of ROS has several major sources, in 
which the pathway of the mitochondrial electron transport chain takes over 90% responsibility of 
ROS formation [10]. It has been demonstrated that ROS is the outstanding contributor to the dis-
ruption of protein function in many diseases, such as ischemia, inflammation and neurodegenera-
tive diseases [11-13]. 
1.1 ROS production, regulation and physiological roles  
Typical reactive oxygen species (ROS) contain superoxide (˙O2
─
), hydrogen peroxide 
(H2O2) and hydroxyl radicals (˙OH). More broadly conceived, singlet oxygen (
1
O2), nitric oxide 
(NO), and peroxynitrite anion also belong to this group. Superoxide anion (˙O2
─
) is the precursor 
2 
of most ROS, which is produced from a one-electron reduced reaction of oxygen. Superoxide 
dismutases catalyzing the dismutation of ˙O2
─
 produce hydrogen peroxide (H2O2), which in turn 
may be partially reduced by catalase to hydroxyl radical (˙OH), one of the strongest oxidant in 
nature, or be completely reduced to water. Major sources of ROS include enzymatic and non-
enzymatic pathways from cell membrane of various cells and some cellular organelles, as perox-
isomes, endoplasmic reticulum and mitochondrion. Enzymatic sources implicate NADPH oxi-
dases (NOX) on the cell membrane of macrophages, endothelial cells and white blood cells and 
cytochrome P450- dependent oxygenases [14]. In vivo, the non-enzymatic production of ROS 
may occur when a single electron is directly transferred to O2 by reduced forms of coenzymes in 
mitochondrial electron transport chain (ETC), or by reduced xenobiotics. The mitochondrial 
electron transport chain is considered as the major source of ROS [10, 15]. 
ROS is regulated on several levels to keep the balance of its generation and scavenging. 
First, several antioxidant enzymes built up the antioxidant defenses, such as superoxide dis-
mutases (SOD) (Fridovich, 1995), catalase (Radi et al. 1991), glutathione peroxidases (GPXs) 
(Chance et al. 1979) and peroxiredoxin (PRXs). Superoxide (˙O2
─
) is converted to hydrogen per-
oxide (H2O2) by SOD. Also, the dismutation can happen spontaneously. Additionally, the pre-
cursor of ˙OH and the product of ˙O2
─
, H2O2, is mostly diminished by GPXs. Catalase is another 
major antioxidant enzyme, decomposing the powerful and damaging H2O2. Except these antioxi-
dant enzymes, vitamin E, also known as ascorbic acid or α-tocophenol, reduced GSH, as antioxi-
dant buffer, cytochrome c, a scavenger of ˙O2
─
,  and nuclear factor-erythroid 2-related factor 2 
(Nrf2) are also the determinants for ROS clearance. Nrf2 is a redox stress-sensitive transcription 
factor which is activated by ROS, working as a detoxification and antioxidant gene regulator. 
3 
These protective systems work together to prevent the deleterious effects of the excessive pro-
duction of ROS. 
The appropriate level of ROS performs significant physiological functions to the body. 
There are evidences suggesting that ROS play physiological roles in regulating signaling path-
ways in various cellular processes, including immune cell activation, adaptation to hypoxia, cel-
lular survival, cell differentiation and aging regulation [10]. Therefore ROS is beneficial to phys-
iological processes in a tightly-controlled manner. 
1.2 Oxidative stress and diseases 
When the production of ROS overwhelms the ameliorative ability of catalase, superoxide 
dismutase and other anti-oxidant factors, ROS causes damage via oxidative stress. In other 
words, oxidative stress is a deleterious consequence of the excessive generation of ROS and rela-
tively antioxidant deficiency. The imbalance of ROS production and antioxidant defense makes 
proteins, lipids and DNA to be the targets of these numerous free radicals. The disrupted balance 
between oxidants and its defenses will result in tissue damage and cell death. There are accumu-
lating studies revealing the relations between oxidative stress and diseases, including inflamma-
tion disorders, diabetes mellitus, cancer, neurodegenerative diseases, cardiovascular diseases and 
atherosclerosis, plus some physiological conditions, such as tissue hypoxia, starvation, radiation 
and increasing age. 
In inflammatory system, oxidative stress may initiate and augment inflammation, and 
may also result from inflammation. ROS is known for the role of directly killing pathogens 
through the oxidative burst by NADPH oxidases (NOXs) and the mitochondrial electron 
transport chain (Mt-ETC) of the phagocytes as well as non-phagocytic cells. The oxidative burst, 
which requires the activation of superoxide, represents one of the first lines of defense against 
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the infected pathogens. Even at the early stage of inflammation, the marked amount of ROS 
could be released. For example, in the microvascular system, the injured endothelial and smooth 
muscle cells release a lot of ROS at the early stage of tissue injury [16]. And more ROS is re-
lease from the phagocytic cells at later stage. The activated phagocytic cells generating ROS uti-
lize NADPH as the major electron donor to convert O2 to ˙O2
─
 and H2O2. Besides working as a 
direct killer, the soaring ROS also induces pro-inflammatory genes coding inflammatory media-
tors, such as IL-1 ,IL-6 and TNF-α, which are regulated by a group of redox-sensitive transcrip-
tion factors, including activator protein-1 (AP-1) and nuclear factor-κB (NF-κB) [15, 17-19]. In 
the process of infection and inflammation, over generation of ROS initiates the tissue injury and 
potential organ failure. 
Hypoxic conditions (hypoxia, 0.3% - 3% O2) are well known as a favorable situation of 
ROS generation. It has been reported that the moderately hypoxic conditions could lead to a 
dramatic increase in oxidative stress [20]. Brain is the top one organ extreme sensitive to the 
change of oxygen level.  By using a standard detection probe of ROS, 2',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA), researches show that hypoxia increases fluo-
rescence in cells (Chandel et al. 2001). Further studies elucidate that the mitochondria is partially 
the actual determinant for the soaring ROS [21, 22]. Still the mechanism that how the ROS is 
formed during hypoxia is unclear, more studies are needed to reveal the truth. 
1.3 ROS toxicity on ion channels 
The harmful effects of ROS are extensive, including damage of DNA, oxidation of lipids, 
inactivation of specific enzymes, and oxidations of amino acids of proteins. Exposure to excess 
ROS may result in post-translational modification, including S-glutathionylation, S-nitrosylation, 
acetylation and phosphorylation, which regulate the cellular function. In point of ion channel, 
5 
previous studies show that S-glutathionylation occurring on ion channels suppresses their func-
tions in oxidative stress.  
S-glutathonylation is a PTM by adding a glutathione (GSH) moiety on the cysteine resi-
dues. GSH, a tripeptide, containing a glycine, a glutamate and a cysteine, is a major donor of S-
glutathionylation during oxidative stress. GSH is the reduced form of oxidized glutathione 
(GSSG), working as an antioxidant factor. The concentration of GSH is varied in different types 
of cells, from 1mM to 5mM. The ratio of reduced glutathione to oxidized glutathione is usually 
considered indicative of oxidative stress, as GSH is over consumed during the process of the 
elimination of ROS. In the presence of H2O2, GSH promotes the reaction of S-glutathionylation, 
while GSSG alone also can perform the PTM of the proteins in experimental studies. 
Ion channels play critical roles in various aspects of the regulation of physiological func-
tion. The studies on the post-translational modifications of ion channels receive more and more 
attention. And S-glutathionylation is one that cannot be ignored. Ryanodine receptor (RyR) is the 
first ion channel identified to be S-glutathionylated [6]. Continued researches demonstrated that 
KATP channels [8, 9] and Cystic Fibrosis transmembrane conductance regulator (CFTR) [7] are 
also targets of S-glutathionylation. S-glutathionylation exclusively happens on cysteine residues 
by adding a glutathione moiety on thiol group [8]. RyR expressed on the endoplasmic reticulum 
is a Ca
2+
 channel, which is highly sensitive to redox and has multiple potential cysteine residues 
under the regulation of S-glutathionylation. The chloride channel, CFTR, regulates the salt and 
water equilibrium between lumens and cytoplastic sides of the epithelial cells in lung and gut. 
Cys344 of CFTR is identified as the primary site under the control of S-glutathionylation. The 
molecular weight of GSH is about 305 Da. The tripeptide structure endues itself relatively big 
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size, which could interrupt the conformational change in open stage of the channel, thus blocking 
the channels. 
1.4 The properties of Kir4.1 and Kir5.1 channels, and their modifications 
The Kir4.1 and Kir4.1-Kir5.1 heteromeric channels are expressed in various tissues, in-
cluding the kidney, retina and brain, responding to the changes in pH and pCO2 within physio-
logical context, playing an important role in pH sensitivity. The basic block of Kir channels is 
two transmembrane helixes; four blocks compose one functional channel. The ion conduction 
pore is composed of three zones: selectivity filter, central cavity and the internal part of the tun-
nel formed by intracellular face of TM2. The transmembrane domains guard the ion selectivity 
and gating, while the cytoplasmic domain functions as a gating regulator. Kir4.1 is predominant-
ly expressed in glial cells of the CNS [23] as a form of homotetrameric functional channel on the 
cell membrane, while Kir5.1expressed alone as a homomeric channel is nonfunctional, and exists 
in the cytoplasm. Kir4.1 and Kir5.1 also coexpress in various tissues, such as the kidney, retina 
and brain. An inside-out patch experiment reveals the pH sensitivity differences between Kir4.1 
homomeric channel and Kir4.1-Kir5.1 heteromeric channel [24]. Kir4.1 current is only slightly 
inhibited (at pH=6.2) during physiological range of the changes of pH. While pH of 6.5 almost 
completely abolished the currents of the coexpressed Kir4.1-Kir5.1 channel. At pH of 7.5, the 
baseline currents of the hetermeric channels are inhibited to 50%. The high sensitivity of Kir4.1-
Kir5.1 channel to the pH extends the physiological function of Kir channels. 
Some studies also suggest that abnormality of Kir4.1 and/or Kir4.1-Kir5.1 channels are 
involved in several pathophysiological conditions, due to their functions in pH sensing [3, 25], 
“spatial buffering of K+” [26], and maintaining the activity of other ionic transporters [27-30]. 
The functional impairment of Kir4.1 and Kir4.1-Kir5.1 channels could happen in various patho-
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physiological conditions, such as oxidative stress. Oxidative stress is known to induce injurious 
PTMs to various channels, such as S-glutathionylation [8]. Furthermore, CNS, cochlea, kidney 
and retina are highly sensitive to redox changes, and are usually the targets in these disease con-
ditions. Thus, the specific expression feature of Kir4.1 and Kir4.1-Kir5.1 channels increases their 
chance for them of being targets of reactive oxygen species (ROS) and other oxidants, leading to 
the S-glutathionylation on critical residue followed by functional blockage of these channels.  
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2     HYPOTHESIS AND SPECIFIC AIM 
Hypothesis: Oxidative stress modifies the transport isoform of the inward rectifying po-
tassium channels by causing the inhibition of K4.1-Kir5.1 channels via S-glutathionylation of 
Kir5.1 subunits. 
Specific aim: to demonstrate that oxidative reagents modify the transport Kir4.1-Kir5.1 
channels via S-glutathionylation of Kir5.1 subunit, and to identify specific amino acid residue in 
the channel protein which is responsible for the S-glutathionylation. 
To address this aim, different tetrameric structures, including Kir4.1-Kir5.1 tandem di-
mer, Kir4.1-Kir5.1 C158A tandem dimer, and a chimera of tandem-tetrameric Kir4.1-Kir5.1 
C158A-Kir4.1-Kir5.1, were constructed. The constructed channels were expressed in mammali-
an HEK system, and the activities of the channels were tested with different oxidants in patch 
clamp studies. Also the involvement of S-glutathionylation was confirmed by immunoprecipita-
tion experiments. 
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3     MATERIALS AND METHODS 
3.1 Chemicals 
Chemicals were purchased from Sigma unless otherwise stated in this study. Powder 
chemicals were dissolved in double-distilled water or DMSO. In the working solution, the con-
centration of DMSO is less than 0.1% (v/v). H2O2 solution, BioGEE solution and glutathione 
solution were prepared freshly before the experiments. 
3.2 Cell preparation 
The cells used in all the studies were human embryonic kidney (HEK) cells (C  -    , 
Batch no.        ,  TCC,  ockville, D,    ). Cells were revived from the stocks, and were 
cultured in Dulbecco’s odified Eagle’s medium (D E )-    with     fetal bovine serum 
( B ) at     C and a 5% CO2 atmosphere. Cells were split with 0.25% trypsin and changed with 
fresh culture medium every three days.  
3.3  cDNA construction 
Rat Kir4.1 cDNA (GenBank # X83585) and rat Kir5.1cDNA (GenBank #X83581) were 
gifts from Dr. John Adelman (Oregon Health Science University, Portland, OR, USA). Commer-
cial vector PcDNA3.1(+) (INVITROGEN, Carlsbad, CA, USA) was used to carry Kir4.1 and 
Kir5.1 cDNA. Tandem dimer were cloned into mammalian expression vector PcNDA3.1(+) by 
polymerase chain reaction (PCR) using Pfu DNA polymerase. The fragment of Kir5.1subunit 
was generated with a stop codon followed by Eco  I recognition sequence on the  ’end, and 
with a fe I recognition sequence on the  ’ end. The stop codon (TG ) of Kir4.  subunit in 
Tandem dimer was mutated to tryptophan (TGG) on the  ’ end. Two sides of the Kir4.1 frag-
ment were flanked with Eco  I sequence on the  ’ end and fe I sequence on the  ’ end sepa-
10 
rately. This design facilitated the mutual DNA ligation, and simplified the screening procedure, 
as both restriction sites were lost after EcoR I- Mfe I ligation. The constructed Kir4.1-
Kir5.1tandem dimer was confirmed by DNA sequencing. Site-specific mutations of Kir5.1 
C158A and C158T were performed using a kit of a site-directed mutagenesis (Stratagene). The 
tandem tetramer of Kir4.1-Kir5.1C158A-Kir4.1-Kir5.1* (* stands for stop codon) was construct-
ed via the same strategy stated previously. The stop codon (TGA) of the Kir5.1 C158A fragment 
in tandem tetramer was mutated to leucine (TTA). The primers used are listed in table 1. All the 
constructions were tested by DNA sequencing. 
Table 1: List of primers for plasmid constructions 
Target gene Primer sequence 
Kir5.1* Fw: AATTCCATGAGCTATTACGGAAG 
Re: ATCCAATTGGCTCACAGCTGCTCACCATG 
Kir5.1 Fw: AATTCCATGAGCTATTACGGAAG 
Re: ATCCAATTGGCTAACAGCTGCTCACCATG 
Kir5.1C158A Fw: GTCCATCCTGAGCGCCATCATAAACAC 
Re: CAGGTAGGACTCGCGGTAGTATTTGTG 
Kir5.1C158T Fw: GTCCATCCTGAGCACCATCATAAACAC 
Re: CAGGTAGGACTCGTGGTAGTATTTGTG 
Kir4.1 Fw: CGGAATTCCATGACATCAGTTGCC 
Re: ATCCAATTGGCCCAGACGTTACTAATG 
Note: * stands for stop codon (TGA). EcoR I sequence and Mfe I sequence are underlined. 
 
3.4 Gene expression 
Target genes were transfected using Lipofectamine
2000
 (Invitrogen, Carlsbad, CA, USA) 
following the instruction. Briefly, 4µg cDNA and 0.5 µg green fluorescence protein (GFP) 
cDNA were incubated with 10µl Lipofectamine
2000
, the mixture was transferred to the 35mm 
dishes with cell density of 60% ~ 90%. After 4 to 6 hrs, solution is changed, and the cells were 
incubated 18 to 36 hrs further with cell culture medium before experiments. 
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3.5  Electrophysiology 
Whole cell currents were recorded with single-electrode whole-cell voltage clamp tech-
nique as described previously (Shi et al. 2007; Yang et al. 2010; Zhang et al. 2011). 1.2 mm bo-
rosilicate capillary glass (Sutter Instruments, Novato, CA, USA) is used to make fire-polished 
patch pipettes. The resistance of the patch electrodes is about   to   Ω.  ignal was amplified 
using amplifier Axopatch 200B (Molecular Devices, Sunnyvale, CA, USA). Current records 
were low-pass filtered, digitized and recorded for further data analysis using the pCLAMP 9 
software (Molecular Devices). Patch solution contains (in mM): KCl 40, K gluconate 90, KF 5, 
Na vanadate 0.1, K pyrophosphate 10, ADP 0.2, PIPES 10, glucose 10, spermine 0.1 and EGTA 
1 (pH was adjusted to 7.4). Inside-out patch clamp was performed on HEK cells.  Bath and pi-
pette solution was prepared as stated previously with same potassium concentration (in mM): 
KCl 40, K gluconate 90, KF 5, Na vanadate 0.1, K pyrophosphate 10, EGTA 1, ADP 0.2, PIPES 
10 and glucose 10 (pH was adjusted to 7.4). Additional 0.1 mM spermine was added into the 
bath solution to elicit inward rectifying current. Single channel currents were recorded with a 
holding potential of -60 mV. Slope command potentials of -100 mV to 100 mV were performed 
to test the channel conductance. Data was analyzed later with Clampfit 10 software (Axon In-
struments). 
3.6 Western blotting and immunoprecipitation 
HEK cells expressing wide-type (WT) Kir4.1-Kir5.1 tandem dimer or mutant Kir4.1-
Kir5.1C158A tandem dimer channels were used to do western blotting. Cells were grown in the 
35 mm dishes, and incubated with fresh medium without FBS for 2 hrs before treatment. Bioti-
nylated glutathione ethyl ester (BioGEE;     μ ) (Invitrogen) then was added to the medium 
for one hr followed by a challenge of 15 min 750 µM H2O2. Excess free BioGEE was removed 
12 
by three washes with PBS. Radioimmune precipitation assay buffer (Sigma) was used to lyse the 
cells. Protein concentration was measured via BCA assay (Thermo Scientific, Waltham, MA). 
Protein lysate was adjusted to   mg/ml.  or the Western blot,   μl samples of both WT and mu-
tant lysates were loaded into a 10% SDS-polyacrylamide non-reducing gel and then transferred 
to a PVDF membrane (Bio-Rad). Rabbit primary antibodies against Kir5.1 (1:1000) (Sigma), 
rabbit primary antibody against GAPDH (1:1,000) and goat-anti-rabbit secondary antibody con-
jugated with horseradish peroxidase (HRP) (1:10,000) (Invitrogen) were used to detect target 
Kir5.1 and endogenous GAPDH bands. Super Signal West Pico chemiluminescent substrate 
(Thermo Scientific) was used for signal visualization. Experiments were repeated at least four 
times. 
For the  pull-down experiments, 100µl cell lysate was used. Before the incubation, the 
Dynabeads were washed three times with washing buffer to remove preservatives. Protein ly-
sates were incubated with Dynabeads®M-280 Streptavidin (Invitrogen) at room temperature for 
30 mins with gentle rotation to purify the biotin-GSH-conjugated proteins. The protein and 
Dynabeads complex was separated from the free proteins by a magnet. The coated beads were 
resuspended and washed three times with washing buffer. The pellets were mixed with 20 µl 
protein loading buffer which contains 0.1% SDS, then the mixture was boiling in a hot water 
bath to release the glutathionylated proteins. 15µl solvent was loaded to the gel for Western blot. 
Kir5.1 antibody and GAPDH antibody were used as described above.  
3.7 Data analysis 
Data were presented as the mean value + SEM. T test was adopted to compare the differ-
ences in means for paired data. If P < 0.05, the differences were considered as significant. 
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4     RESULTS 
4.1 Kir5.1 subunit is the target of reactive oxygen species (ROS) 
Kir4.1 monomer and Kir4.1-Kir5.1 tandem dimer were cloned into mammalian expres-
sion vector PcNDA3.1(+) by PCR, and transfected into mammalian expression system, HEK 
cells. DNA sequencing test confirmed the correct sequence of the channels. The transfected 
Kir4.1 cDNA alone automatically expressed homotetrameric Kir4.1 channels. The constructed 
K4.1-Kir5.1 tandem dimer secured accurate expression of the heterologous system. Co-
transfected green fluorescent protein (GFP) nicely indicated the HEK cells which expressed 
functional channels. A series of -100 mV to 100mV voltage commands were applied to the GFP-
positive cell with each pulse of an increment of 20 mV and duration of 400 ms. A holding poten-
tial of 0 mV was given to the cell in equal 145 mM potassium concentration of both pipette and 
bath solution. The transfected cells showed typical inward rectifying currents. A series of H2O2 
concentration from 100 µM to 1mM we applied to the sealed and ruptured cells after several-
minutes balance. The currents of Kir4.1-Kir5.1 channels were inhibited in a concentration-
dependent manner of H2O2 (Fig.1.1A). 100 µM H2O2 gave 15 + 5% inhibitory effect to the heter-
omeric channels. When the concentration of H2O2 reached 1mM, a maximum effect was record-
ed as the Kir4.1-Kir5.1 currents decreasing by 55 + 5% (n=5) (Fig.1.1B). 
   
14 
 
Figure 1.1. Kir5.1 subunit is the target of reactive oxygen species (ROS). A. Kir4.1-Kir5.1 
channels were expressed on HEK cells, whole-cell currents were studied on single HEK cell. A 
series of -100 mV to 100mV voltage commands were applied to the cell with an increment of 20 
mV and duration of 400 ms each. A holding potential of 0 mV was given to the cell with even 
potassium concentration of 145 mM in both pipette and bath solution. B. The current of different 
concentration of H2O2 was summarized and normalized (n=5). C, D. Exposure of Kir4.1-Kir5.1 
channels to oxidant diamide with concentration of 30 and 300 mM (n=5). E, F. The effect of di-
amide on homomeric Kir4.1 channel (n=4). Data is shown as means + SEM. 
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15 
Other oxidant also showed inhibitory effect to the heteromeric channels. Diamide, report-
ed to be used as a thiol oxidizing agent and specific glutathione oxidant, was used to get the 
similar inhibitory effect on Kir4.1-Kir5.1 channel in a concentration-dependent manner. The cur-
rents of Kir4.1-Kir5.1 channels were inhibited by 25 + 5% with a challenge of 30 µM diamide, 
and by 67 + 5% with a challenge of 100 µM diamide (n=5) (Fig. 1.1 C, D). Another oxidant, 2, 
 ’-Dithiodipytidine (2-DTP), which is sulfhydryl group specific oxidant of cysteine residue, was 
applied to Kir4.1-Kir5.1 channels. The whole-cell record showed a significant decrease of chan-
nel current by 56 + 5% (n=5) with a single dose of 50µM 2-DTP (Fig. 1.2 A, B). As we previ-
ously mentioned, 2-DTP, a membrane-permeable oxidant, belongs to pyridine disulfides (PDSs) 
which selectively oxidize sulfhydryl group or thiol group of cysteine residue (Yang et al. 2010; 
Yoshida et al. 2006).  
However, the treatment of diamide had little effect on inward rectifying currents of 
Kir4.1. High concentration of H2O2 (1 mM) showed only 8 + 5% inhibitory effect to Kir4.1 cur-
rents (date did not show here). And the Kir4.1 channel was only inhibited slightly by 7 + 5% 
with 100 µM (n=4) (Fig. E, F). 50 µM 2-DTP inhibited the homomeric Kir4.1 channels by only 
7 + 5% (n=6) (Fig. 1.2 C, D). 
Therefore, these results suggest that different kinds of oxidants, including H2O2, diamide 
and 2-DTP, target on the heteotetrameric Kir4.1-Kir5.1 channel, instead of the homotetrameric 
Kir4.1 channel. The sensitive subunit to oxidants may be Kir5.1 via mediation of oxidation on 
thiol groups. 
16 
 
Figure 1.2. Pyridine disulfide inhibits the Kir4.1-Kir5.1 channel but not Kir4.1 channel. A. 
A membrane permeable 2,  ’-Dithiodipytidine (2-DTP, 50µM), which is sulfhydryl group spe-
cific oxidant of cysteine residues, was applied on Kir4.1-Kir5.1 channels. Currents of whole-cell 
recording were studied with –100 to 100mV voltage commands. The heteromeric channels were 
inhibited by the treatment of 50µM 2-DTP. B. Normalized results were compared (n=5; ***, P < 
0.001). C, D. Application of cysteine specific oxidant has little effect on the homomeric Kir4.1 
channels. 
 
4.2 The critical protein domain is located on the intracellular side 
The oxidants used in our experiments have similarities. First, they perform an ability to 
oxidize the reduced glutathione (GSH) to disulfides. In other words, they all have the possibility 
to exert the reaction of S-glutathionylation. Additionally, these reagents are membrane-
permeable. The common features of these oxidants raise another question: whether the location 
of oxidation site of Kir5.1 is on the intracellular or extracellular side.  
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Figure 2.1. Critical protein domain of Kir5.1 subunit is on the intracellular side. A. The 
membrane-permeable pyridine disulfide, 2, 2’-dithiobis-5-nitropyridine (DTNP, 50 μM) inhibit-
ed whole-cell currents of Kir4.1-Kir5.1 channels strongly. B. The membrane-impermeable cyste-
ine specific oxidant, 5, 5’-dithiobis-2-nitrobenzoic acid (DTNB, 200 µM) did not inhibit the 
whole-cell currents of Kir4.1-Kir5.1. C. Summary of the effects of membrane-permeable and 
membrane-impermeable PDSs on Kir4.1- Kir5.1 currents (n=5; **, P < 0.005). D, E. Current 
studies were performed in inside-out patch experiments. The reagents were added in the bath so-
lution (intracellular side). Membrane potential was hold at 0mV, and a ramp voltage from -100 
mV to 100mV was exerted to the electrode. Currents of Kir4.1-Kir5.1 were inhibited by both 
DTNP and DTNB markedly. F. Currents with different agents were compared (n=4-6; **, P < 
0.005). 
 
In the family of pyridine disulfides, two other pyridine disulfides (PDSs), a membrane-
permeable pyridine disulfide, 2, 2’-dithiobis-5-nitropyridine (DTNP), and a membrane-
impermeable cysteine specific oxidant, 5, 5’-dithiobis-2-nitrobenzoic acid (DTNB), were used to 
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18 
identify the critical domain of Kir5.1 subunit. Similar to 2-DTP, 50 µM DTNP inhibited the 
whole-cell currents of Kir4.1-Kir5.1 channels by 49 + 5% (n=5) (Fig. 2.1 A, C). However, 
whole-cell recording of the heteromeric channels indicated a very little inhibitory effect by only 
1 + 5% (n=5) (Fig. 2.1 B, C) with the challenge of membrane-impermeable DTNB (high concen-
tration, 200 µM). While the inside-out patch currents with both DTNP and DTNB were marked-
ly inhibited by 52 + 7% and 45 + 8% (n=4-6) respectively at equal concentration of 50µM (Fig. 
2.1 D, E, F). These results suggest that the critical oxidized domain of the Kir4.1-Kir5.1 channel 
by different oxidants is located on the intracellular side. 
4.3 S-Glutathionylation of Kir5.1 inhibits the functional channel 
Protein were expressed in HEK    cells in D E  with     fetal bovine serum at     C 
with a 5% CO2 explosion. The groups of blank HEK293 cells (B) and empty vector 
PcDNA3.1(+) transfected cells (P) were set as control groups. And the Kir4.1-Kir5.1 channel 
transfected groups are considered as experimental group.  The western blot results did not show 
any band in the two blank control groups (B and P) in Kir5.1 detection study (Fig. 4.2 A). Cells 
were incubated with BioGEE (    μ ) (Invitrogen) for  hr and further incubated with    μ  
H O  for    mins at     C to induce  -glutathionylation. Biotinylated protein was purified by 
using Dynabeads®M-280 Streptavidin (Invitrogen), and detected using Kir5.1 specific antibody. 
A dark band of Kir5.1 was shown in the pull-down experiment (Fig. 4.1 B), confirming the in-
volvement of S-glutathionylation on Kir5.1 peptide.  
19 
 
Figure 3.1. Oxidized glutathione inhibites the Kir4.1-Kir5.1 channel. A, B. 300 µM reduced 
glutathione combined with 300 µM H2O2 (H2O2/GSH), or 300 µM reduced glutathione com-
bined with 30 µM diamide (DIA/GSH) markedly inhibited the current of Kir4.1-Kir5.1channels. 
C, D, E. Oxidants (H2O2 or DIA) or glutathione (GSH) alone had limited effect on the current of 
channels. F. Summary of the effects of different reagents is shown (n=5-6; ***, P < 0.001). 
 
The introduction of the oxidants suggested the existence of the oxidation of the thiol 
group specifically on cysteine residues. What’s more, the effects of the diamide and PD s also 
provided the possibility of an occurrence of the modification of S-glutathionylation rather than 
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20 
simple formation of disulfide bonds. Therefore, we tested the potential formation of the special 
modification, S-glutathionylation, by inside-out patch studies with glutathione reagents. 300 µM 
reduced glutathione combined with 300 µM H2O2 (H2O2/GSH), or 300 µM reduced glutathione 
combined with 30 µM diamide (DIA/GSH) were used to introduce S-glutathionylation. A com-
bination of H2O2/GSH and DIA/GSH markedly inhibited the current of Kir4.1-Kir5.1channels by 
46 + 4% (n=5) and 49 + 5% separately (n=6) (Fig. 3.1 A, B, F). However, the application of 
H2O2 or diamide alone did not induce the obvious inhibitory effect on Kir4.1-Kir5.1 heteromeric 
channels, neither did reduced glutathione (GSH) (Fig. 3.1. C, D, E, F). In the presence of H2O2, 
GSH is switched to an oxidized form, GSSG. Both GSH/H2O2 and GSSG have the possibility to 
modify cysteine residues of certain proteins. Inside-out patch studies showed the Kir4.1-Kir5.1 
channels were inhibited by 16 + 4% (n=5) and 58 + 7% (n=5) respectively with the exposure of 
2.5 mM and 5.0 mM GSSG on the intracellular side of the membrane (Fig. 3.2). The inhibitory 
effect on herterimeric channels is in a concentration-dependent mannar. These results strongly 
suggest the involvement of S-glutathionylation of Kir5.1. 
21 
 
Figure 3.2. S-Glutathionylation of Kir5.1 inhibits the function of Kir4.1-Kir5.1 channel. A. 
Inside-out patch studies were done with the exposure of 2.5 mM and 5.0 mM oxidized 
flutathione (GSSG) on the intracellular side of the membrane. The inhibitory effect on Kir4.1-
Kir5.1 channels is in a concentration-dependent mannar. B. The effects of GSSG was 
summarized (n=5; *, P < 0.05; C). 
 
4.4 The primary target of S-glutathionylation of Kir5.1 is Cys158 
After screening of the sequence of Kir5.1 cDNA, we found that there are five cysteine 
residues in the inside domain of Kir5.1 peptide, in which there is only one cysteine, Cys158, lo-
cated in the second transmembrane domain (TM2) of Kir5.1. Previous studies of another Kir 
channel demonstrate that the TM2 is the critical domain of S-glutathionylation (Yang et al. 2010, 
2011). Therefore, this Cys158 is highly possible of the critical residue in S-glutathionylation. 
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22 
The site-specific mutation study was performed on the only cysteine of Kir5.1 peptide to reveal 
the S-glutathionylation mechanism of Kir4.1-Kir5.1 channel. Related Cys158 (TGC) was re-
placed by alanine (A, GCC) or threonine (T, ACC) via PCR reaction by designed primers. Mu-
tated Kir channels were expressed in HEK293 cells. The mutation of Kir5.1 C158A or C158T 
eliminated the inhibitory effects with the exposure of 5.0mM GSSG and 50µM DTNP in inside-
out patch study (Fig. 4.1).  
The S-glutathionylated proteins were purified and detected in immunoprecipitation ex-
periments. Tandem dimer Kir4.1-Kir5.1 C158A protein is expressed in mammalian HEK cell 
system, and S-glutathionylated Kir5.1 peptide was detected with the specific antibody via west-
ern blot experiments. The mutation of Kir5.1 did not change the peptide density at the expected 
size (monomeric Kir5.1 is about 50 KDa) (Fig. 4.2 A). After the treatment of BioGEE followed 
by challenge of H2O2, the S-glutathioylated protein was purified with Dynabeads system. In the 
pull-down experiments, the S-glutathioylated Kir5.1 peptide is markedly reduced, comparing to 
the wide type one (Fig. 4.2 B). The normalized results show the relative density of glutathi-
onylated Kir5.1 is diminished by 74 + 12% (Fig. 4.2 C). These results suggested the critical cys-
teine residue of Kir5.1peptide is Cys158.  
 
23 
 
Figure 4.1. Cyst158 is the critical S-glutathionylation site. A, B. Mutation of Cys158 to other 
amino acids prohibit the inhibitory effect of GSSG in inside-out patch studies. C,D. Mutation 
eliminated the effect of membrane-permeable DTNP. E. Currents of channels were significantly 
diminished by the mutation of Cys158 (n=6, **, P < 0.01; ***, P < 0.001). 
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Figure 4.2. Mutation of Cys158 decreased S-glutathionylated Kir5.1 markedly. A. Western 
blot showed the C158A mutation had the same density of the band as wide-type Kir4.1-Kir5.1 
peptide. GAPDH was the endogenous control. The size of monomeric Kir5.1 is about 50 KDa 
(B, blank HEK cells; P, PcDNA 3.1(+) vector; WT, wide-type Kir4.1-Kir5.1 tandem dimer; 
C158A, mutant protein with mutation of C158A on Kir5.1). B. The S-glutathionylated proteins 
were purified, and S-glutathionylated Kir5.1 peptide was indicated as the arrow. The density of 
the C158A Kir5.1 band is markedly reduced, compared to the wide type one. C. The density of 
wide-type Kir5.1 and C158A Kir5.1 peptide was analyzed and normalized with ImageJ system 
(n=7; ***, P < 0.001). 
 
25 
4.5 One glutathione is sufficient to inhibit the channel 
 
Figure 5.1. The responses of channel with single mutation to different oxidants are intact. 
A, C. In whole-cell studies, heteromeric channels with single mutation of Cys158 on Kir5.1 still 
had inhibitory responses to both diamide and DTNP. B, D. The responses to diamide and DTNP 
of wide-type channel and mutant with single C158A on Kir5.1were compared, indicating that the 
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26 
inhibitory level of channels with single mutation of Kir5.1 were similar to the wide-type one in 
the challenge of 30µM diamide and 50µM DTNP (n=4-6; **, P < 0.01; ***, P < 0.001). E, F. 
Similar effects were observed in inside-out experiments with the challenge of GSSG (n=4-6; **, 
P < 0.01; ***, P < 0.001). 
 
The channels generated by transfection of Kir4.1-Kir5.1 C158A cDNA have two mutated 
Cys158 based on the tetrameric structure of Kir channel. Therefore, it is necessary to reveal how 
many cysteine residue is involved in modifying the function of the Kir4.1-Kir5.1 channel. The 
chimeric tetramer was generated in a sequential series of monomer, tandem dimer, tandem trimer 
and tandem tetramer to get the structure with only one mutated Cys158. Functional channels 
were expressed in HEK system. The current of the Kir4.1-Kir5.1C158A-Kir4.1-Kir5.1* tandem 
tetramer was inhibited by the similar level of the current of wide-type Kir4.1-Kir5.1 tandem di-
mer with the exposure of 30µM diamide or 50µM DTNP (Fig. 5.1 A, B) in whole cell recording 
experiments. The inside-out studies also showed that the inhibitory effect of the tandem tetramer 
carrying one mutation was also remarkable as the wide-type one with 5mM GSSG exposure 
(Fig. 5.1 C). In view of these studies, one glutathione is sufficient to hinder the function of the 
Kir4.1-Kir5.1 channel. 
 
 
 
 
 
 
 
 
27 
5     DISCUSSION 
The imbalance between the production of ROS and protective reducing environment can 
cause toxic effects through the overproduced free radicals and peroxides, which may damage the 
cellular components, such as lipids, DNA and proteins. When the production of the reactive oxy-
gen species (ROS) exceeds the cleaning ability of the cellular antioxidant system, the oxidative 
stress occurs. The disturbance, oxidative stress, is involved a number of disease conditions, in-
cluding inflammation disorders, diabetes mellitus, cancer, neurodegenerative diseases, cardio-
vascular diseases, tissue hypoxia, radiation and increasing age. Some of the disorders are related 
to post-translational modification, such as acetylation [31], S-nitrosylation [32-34], S-
glutathionylation [6-9, 35-37] by the addition of small chemical groups. Within these post-
translational modifications, S-glutathionylation is what we are most concerned. Potassium 
transport channels of functional Kir4.1 channel and nonfunctional Kir5.1 channel as potential 
target of ROS in different pathophysiological conditions expressed on the cell membrane and in 
the cytoplasm respectively. Co-expression of Kir4.1 and Kir5.1 exists in various tissues, such as 
the kidney, retina and brain which are susceptible targets of oxidative stress. The disorder of the 
potassium channels by oxidative stress can severely threaten the normal operation of the function 
of the cells. 
Indeed, our studies show that the Kir4.1 and Kir5.1 channel is the target of several oxi-
dants, as the heteromeric channel is inhibited by H2O2, diamide and PDSs by different degree. 
While, these oxidants barely have influence on the homomeric Kir4.1 channel. As small mole-
cule, addition of the external H2O2 generated a concentration gradient through cell membrane, 
building up the oxidative environment to mimic oxidative stress. Diamide was reported as a rea-
gent for the intracellular oxidation of glutathione to the disulfide [38]. PDSs have the propensity 
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of cysteine residues within a peptide or protein with the consequence of reversible disulfide 
bond. All these features suggest the generation of S-glutathionylation on available Cys -SH 
groups in oxidative stress. Additionally, the effects of various compounds of PDSs in whole cell 
and inside-out studies reveal that the certain domain responding to oxidants is located in the in-
ner side of cellular membrane. To sum up, the Kir5.1 is the major subunit which responds to oxi-
dative stress in Kir4.1-Kir5.1 channel, and the major domain responsible for redox reactions is 
located intracellularly. 
To demonstrate the redox mechanisms of the Kir4.1-Kir5.1 channel, we studied the ef-
fects of specific S-glutathionylation donors, including a combination of GSH and H2O2, GSH 
and diamide, and GSSG. GSH, as reported as non-enzymatical antioxidant, reacts directly with 
oxidants, such as ˙O2
─
, NO, H2O2 and ˙OH, to inhibit oxidative stress in the cell. What’s more, 
GSH reacts with redox enzymes, including GSH-S-transferase (GST) and GSH peroxidase 
(GPx), which perform the cytoprotection against neurodegeneration [39]. In the process of stress 
disposal, oxidative stress leads to the accumulation of GSSG from the reaction between GSH and 
H2O2. The excessive production of GSSG facilitates the S-glutathonylation of proteins, making 
them as cellular targets of oxidative stress [40-42]. The S-glutathionylation triggered by the po-
tent inducers markedly impaired the function of the Kir4.1-Kir5.1 channel. Therefore, the re-
versible S-glutathionylation may be a common factor in the regulation of the redox sensitive Kir 
channels in oxidative stress.  
The cysteine residue Cys158 on the intracellular side of Kir5.1 peptide is demonstrated as 
the major residue responsible for S-glutathionylation based on the patch clamps studies and im-
munoprecipitation results. Previous studies on one member of KATP family provide some sugges-
tions about the blocking mechanism of Kir channel by S-glutathionylation (Yang et al. 2010, 
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2011). KATP channels share the similar structure that four pore forming Kir subunits surrounded 
by four sulphonylurea receptors (SUR) of the ATP sensitive cassette [43]. Systematic mutational 
analysis revealed Cys176 on inner part of Kir6.1 transmembrane domain was the prominent site 
contributing to more than 80% of the channel inhibition. And the mechanism is due to that the 
conjugated glutathione moiety occupied the margin between two transmembrane helixes and the 
slide helix, preventing the conformational changes of channel gating [8, 9]. Through systematic 
mutational analysis, four cysteine residues are suspected as the target of ROS in the inside do-
main of Kir5.1, in which Cys158 is located in the inner side of second transmembrane domain 
(TM2) of Kir5.1 (Fig. 6.1). A membrane-impermeable PDS, DTNB, did not have the inhibitory 
effect on the activity of the Kir4.1-Kir5.1 channel when DTNB was only placed in the extracel-
lular solution. A glutathione moiety which is applied intracellularly possibly encroaches on the 
crucial Cys158, preventing the channel from opening. Of course, it is possibility there are other 
cysteine residues responsible to S-glutathionylation. Totally, nigh cysteine residues are found in 
the sequence of Kir5.1, in which five of them is located intracellularlly. However the modifica-
tion of other cysteines by ROS is only modest, as suggested by the immunoprecipitation assay. 
To summarize, the critical residue occupied by the glutathione moiety, which inhibits the activity 
of the channel, is residue Cys158.  
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Figure 6.1. Structural model reveals the location of Cys158 in Kir5.1 subunit. The side view 
of Kir5.1 subunit exhibits the pore-forming domains of two monomeric Kir5.1 subunits. The 
black arrows indicates pore-loop (P-loop), transmenbrane domain 1 and 2 (TM1and TM2), 
Cys158 and possible location of Glutathione separately.  
 
The crystallographic structure of Kir4.1 -Kir5.1 channel indicates there are two Cys158 
residues in the TM2 of pore-forming domain which nears or is in the central cavity of the con-
ductive tunnel (Fig. 6.1). However, the inner diameter of cavity (about 10 Å) which involves 
Cys158 is only slightly larger than the size of the glutathione moiety (about 8 Å). In addition, our 
results suggest that only single glutathione moiety is needed for the blockage of the channel. 
Thus, we have reasons to conjecture that the free space of the inner cavity surrounded by do-
mains containing Cys158 could only accommodates one glutathione, and the incorporated gluta-
thione moiety facing the inner cavity may prevent the channel from a fully opening stage by hin-
 -     
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dering the conformational changes. The occupation of the space by the glutathione moiety may 
also prevent the flow of the ions, therefore impairing the channel activity. 
Oxidative stress is a hallmark of many diseases, including diabetic retinopathy, immuno-
disorder, cardiovascular diseases, neurodegenerative diseases, cancer, lung diseases, etc. The 
changes of S-glutathionylation of specific proteins are related to these diseases. Kir channels 
have been identified as substrate of reversible S-glutathionylation, but few study demonstrated 
the S-glutathionylation dependent changes in functional Kir4.1 and Kir5.1 channels in physio-
logical and pathophysiological contexts. Our studies of S-glutathionylation on Kir channels make 
a step closer to reveal the molecular mechanisms of redox related diseases. 
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